Article
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling.
Clinical cancer research : an official journal of the American Association for Cancer Research - 3 Sept 2024
El Zarif Talal, Meador Catherine B, Qiu Xintao, Seo Ji-Heui, Davidsohn Matthew P, Savignano Hunter, Lakshminarayanan Gitanjali, McClure Heather M, Canniff John, Fortunato Brad, Li Rong, Banwait Mandeep K, Semaan Karl, Eid Marc, Long Henry, Hung Yin P, Mahadevan Navin R, Barbie David A, Oser Matthew G, Piotrowska Zofia, Choueiri Toni K, Baca Sylvan C, Hata Aaron N, Freedman Matthew L, Berchuck Jacob E
Abstract excerpt
PURPOSE: Histologic transformation to small cell lung cancer (SCLC) is a mechanism of treatment resistance in patients with advanced oncogene-driven lung adenocarcinoma (LUAD) that currently requires histologic review for diagnosis. Herein, we sought to develop an epigenomic cell-free DNA (cfDNA)-based approach to noninvasively detect small cell transformation in patients with EGFR mutant (EGFRm) LUAD....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
